Woolworths-backed telehealth start-up Eucalyptus has doubled its annual revenue to almost $250 million as sales of GLP-1 weight loss drugs boomed across Australia and the United Kingdom.
The Sydney-headquartered company, which launched life as a collection of consumer retail brands in 2018, has become Australia’s largest online weight-loss medication company thanks to the success of its two brands, Pilot and Juniper.
Loading…
Leave a Reply